Immutep Ownership

IMMP Stock

USD 1.91 0.11 5.45%

Immutep Ltd ADR has a total of 145.46 Million outstanding shares. Roughly 93.72 (percent) of Immutep outstanding shares are held by general public with 0.01 % owned by insiders and only 6.27 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Some institutional investors establish a significant position in stocks such as Immutep in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Immutep, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

As of 11/27/2024, Dividend Paid And Capex Coverage Ratio is likely to drop to -921.89. As of 11/27/2024, Common Stock Shares Outstanding is likely to grow to about 1.3 B, while Net Loss is likely to drop (37.7 M).

Market Cap Enterprise Value

Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Immutep Stock Ownership Analysis

The book value of the company was currently reported as 0.13. The company recorded a loss per share of 0.23. Immutep Ltd ADR last dividend was issued on the 28th of December 2016. The entity had 3:10 split on the 28th of December 2016. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To learn more about Immutep Ltd ADR call Marc Voigt at 61 2 8315 7003 or check out https://www.immutep.com.

Immutep Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Immutep is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immutep Ltd ADR backward and forwards among themselves. Immutep's institutional investor refers to the entity that pools money to purchase Immutep's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Lpl Financial Corp	2024-09-30	31.3 K
Group One Trading, Lp	2024-06-30	31 K
Bnp Paribas Arbitrage, Sa	2024-06-30	27.3 K
Rhumbline Advisers	2024-06-30	26.2 K
Simplex Trading, Llc	2024-06-30	23.5 K
Citadel Advisors Llc	2024-09-30	19.7 K
Geode Capital Management, Llc	2024-09-30	18.7 K
Virtu Financial Llc	2024-06-30	18.6 K
Xtx Topco Ltd	2024-09-30	16.7 K
Blackrock Inc	2024-06-30	839.1 K
Meridian Wealth Management, Llc	2024-06-30	381.2 K

Note, although Immutep's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immutep Outstanding Bonds

Immutep issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Immutep Ltd ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Immutep bonds can be classified according to their maturity, which is the date when Immutep Ltd ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Boeing Co 2196 Corp Bond US097023DG73	View
	US45258LAA52 Corp Bond US45258LAA52	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	MGM Resorts International Corp Bond US552953CD18	View
	AerCap Global Aviation Corp Bond US00773HAA59	View

View All Immutep Corporate Bonds

Immutep Corporate Filings

6K	15th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.	View Verify
13A	12th of November 2024 An amended filing to the original Schedule 13G	View Verify
	22nd of October 2024 Other Reports	View Verify

Pair Trading with Immutep

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.

Moving together with Immutep Stock

0.62	ME	23Andme Holding	Pair Corr
0.76	VALN	Valneva SE ADR	Pair Corr
0.64	JNJ	Johnson Johnson Sell-off Trend	Pair Corr

Moving against Immutep Stock

0.74	KZR	Kezar Life Sciences	Pair Corr
0.7	MLYS	Mineralys Therapeutics,	Pair Corr
0.33	MDGL	Madrigal Pharmaceuticals	Pair Corr

The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.

The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC